Sunshine Biopharma Inc.
publicNasdaq: SBFMsec discovery- Last signal
- Active signals
- 23 of 46
- Confidence
- 80%
Signal score, not a calibrated probability · config v1 · scores
SCORE BREAKDOWN
Why it scores this way
Raising the score
decayed points- IPO+17.8 points added to the scoreFiling Evidence5 signals after decay · component at 89/100, weighted 20% of the dimension
- IPO+8.7 points added to the scoreRegulatory Evidence37 signals after decay · component at 54/100, weighted 16% of the dimension
- IPO+8.0 points added to the scoreFinancial Maturitycompany is already public
- IPO+4.0 points added to the scoreMarket Conditions201 S-1/F-1 filings on EDGAR in last 90d vs baseline 60
- IPO+3.0 points added to the scoreRecencymost recent supporting signal 2d old (recency factor 0.99)
- IPO+0.1 points added to the scoreCorporate Restructuring3 signals after decay · component at 3/100, weighted 5% of the dimension
Holding it back
No contradicting evidence, and nothing has decayed materially yet.
Points are shown after time decay and source-quality weighting. Evidence loses weight on a half-life of IPO 90d · TOK 120d · CHAIN 180d and is dropped entirely after 730 days. Scoring configuration v1. This is a signal score, not a calibrated probability.
Showing component-level attribution. Which individual filing or article moved each component — and the day-over-day change explanation — is part of Pro. Compare plans →
What changed
- Last 10 days
- +9.111.7 → 20.8
- Last 24 days
- +18.82.0 → 20.8
Evidence detected in the last 7 days
- Form 8-K current report+0.5
8-K filed by Sunshine Biopharma Inc. — FORM 8-K
OfficialSEC EDGAR - Other SEC filing+0.3
424B3 filed by Sunshine Biopharma Inc. — FORM 424B3
OfficialSEC EDGAR - S-1 registration statement filed+12.9
S-1 filed by Sunshine Biopharma Inc.
OfficialSEC EDGAR - Form 8-K current report+0.4
8-K filed by Sunshine Biopharma Inc. — CURRENT REPORT
OfficialSEC EDGAR
These are scored events the pipeline retrieved inside the window. A move is not only new evidence: existing signals also lose weight to time decay, corroboration can change, and company attributes such as funding or status can move a component. This list is limited by your plan, so there may be more.
ProHow much of the move was each factor
The windows and the evidence above are the whole free picture: what moved, and what arrived. Pro decomposes the move itself into new evidence, decay, corroboration and attribute changes, per dimension.
- Points from new evidence versus points lost to decay
- Corroboration and source-quality changes, separated
- Attribute changes: funding, valuation, status
- Any two dates, not just the fixed windows
Trend
| Company | IPO | Token | On-chain | Momentum |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | 43 | 0 | 0 | |
| Optimi Health Corp. | 40 | 0 | 0 | |
| Onconetix, Inc. | 39 | 0 | 0 | |
| Moleculin Biotech, Inc. | 47 | 0 | 0 | |
| Veradermics, Inc | 48 | 0 | 0 | |
| HCW Biologics Inc. | 53 | 0 | 0 |
PROFILE
- Founded
- not on record
- Employees
- not on record
- Latest valuation
- none on record
- Latest round
- none on record
- Total funding
- none on record
- Major investors
- none on record
- Executives
- none on record
- Aliases
- Sunshine Biopharma Inc. · Sunshine Biopharma, Inc · Mountain West Business Solutions, Inc · mountain state business solutions,inc
IPO SIGNAL SCORE
- Signal score
- 41.6 signal score — not a calibrated probability
- IPO readiness
- 35.0 structural (maturity, funding, valuation)
- Timeline estimate
- prediction already public
- Filing status
- fact PUBLIC
- Public/private
- public
- Known banks
- none detected
- Advisors
- none detected
- Filing Evidence17.8 / 20.0 pts5 signals · 5 decayed signal(s), mass 120.4 → 88.8/100 (k=55) × weight 0.2
- Regulatory Evidence8.7 / 16.0 pts37 signals · 37 decayed signal(s), mass 47.1 → 54.4/100 (k=60) × weight 0.16
- Financial Maturity8.0 / 8.0 ptsCompany attribute · company is already public
- Market Conditions4.0 / 4.0 ptsCompany attribute · 201 S-1/F-1 filings on EDGAR in last 90d vs baseline 60
- Recency3.0 / 3.0 ptsCompany attribute · most recent supporting signal 2d old (recency factor 0.99)
- Corporate Restructuring0.1 / 5.0 pts3 signals · 3 decayed signal(s), mass 1.2 → 3.0/100 (k=40) × weight 0.05
- Executive Evidence0.0 / 8.0 ptsCompany attribute · no signals in window
- Liquidity Evidence0.0 / 6.0 ptsCompany attribute · no signals in window
- Valuation Maturity0.0 / 8.0 ptsCompany attribute · no valuation on record
- Funding Maturity0.0 / 8.0 ptsCompany attribute · total funding unknown, latest round unknown
- Banking Evidence0.0 / 14.0 ptsCompany attribute · no signals in window
41.6 points total, out of 100 available at these weights.
- Form 8-K current report+0.5
8-K filed by Sunshine Biopharma Inc. — FORM 8-K
OfficialSEC EDGAR - Other SEC filing+0.3
424B3 filed by Sunshine Biopharma Inc. — FORM 424B3
OfficialSEC EDGAR - S-1 registration statement filed+12.9
S-1 filed by Sunshine Biopharma Inc.
OfficialSEC EDGAR - Form 8-K current report+0.4
8-K filed by Sunshine Biopharma Inc. — CURRENT REPORT
OfficialSEC EDGAR
TOKENIZATION SIGNAL SCORE
- Signal score
- 0.0
- On-chain readiness
- 0.0
- Tokenization partners
- none detected
- Custody
- none detected
- Transfer agent
- none detected
- Exchanges / venues
- none detected
- Settlement
- none detected
- Blockchains
- none detected
- Regulatory Readiness0.0 / 8.0 ptsCompany attribute · no signals in window
- Recency0.0 / 4.0 ptsCompany attribute · no recent signals
- Explicit Statements0.0 / 18.0 ptsCompany attribute · no signals in window
- Executive Statements0.0 / 8.0 ptsCompany attribute · no signals in window
- Custody Infrastructure0.0 / 7.0 ptsCompany attribute · no signals in window
- Exchange Relationships0.0 / 8.0 ptsCompany attribute · no signals in window
- Blockchain Partnerships0.0 / 10.0 ptsCompany attribute · no signals in window
- Securities Infrastructure0.0 / 12.0 ptsCompany attribute · no signals in window
- Settlement Infrastructure0.0 / 8.0 ptsCompany attribute · no signals in window
- Tokenization Partnerships0.0 / 17.0 ptsCompany attribute · no signals in window
0.0 points total, out of 100 available at these weights.
- Custody0.0 / 12.0 ptsCompany attribute · no signals in window
- Settlement0.0 / 12.0 ptsCompany attribute · no signals in window
- Kyc Aml Readiness0.0 / 10.0 ptsCompany attribute · no signals in window
- Tokenization Provider0.0 / 14.0 ptsCompany attribute · no signals in window
- Blockchain Integration0.0 / 12.0 ptsCompany attribute · no signals in window
- Transfer Infrastructure0.0 / 12.0 ptsCompany attribute · no signals in window
- Regulatory Compatibility0.0 / 12.0 ptsCompany attribute · no signals in window
- Securities Infrastructure0.0 / 16.0 ptsCompany attribute · no signals in window
0.0 points total, out of 100 available at these weights.
No evidence of this kind on record.
Signal timeline
- REGULATORYForm 8-K current report+0.5
8-K filed by Sunshine Biopharma Inc. — FORM 8-K
Items: 8.01
OfficialSEC EDGARHow this scored
- IPO+0.49 ptsdecay ×0.99Form 8-K current report: base 8 × strength low × source quality 1.00 (tier 1) × corroboration 1.00 (0 independent) × confidence 0.95
- items
- 8.01
- formType
- 8-K
- accessionNumber
- 0001683168-26-007090
- REGULATORYOther SEC filing+0.3
424B3 filed by Sunshine Biopharma Inc. — FORM 424B3
OfficialSEC EDGARHow this scored
- IPO+0.34 ptsdecay ×0.97Other SEC filing: base 6 × strength low × source quality 1.00 (tier 1) × corroboration 1.00 (0 independent) × confidence 0.90
- formType
- 424B3
- accessionNumber
- 0001683168-26-007017
- IPOS-1 registration statement filed+12.9very high
S-1 filed by Sunshine Biopharma Inc.
OfficialSEC EDGARHow this scored
- IPO+12.87 ptsdecay ×0.89S-1 registration statement filed: base 100 × strength very_high × source quality 1.00 (tier 1) × corroboration 1.00 (0 independent) × confidence 0.98
- formType
- S-1
- accessionNumber
- 0001683168-26-006779
- REGULATORYForm 8-K current report+0.4
8-K filed by Sunshine Biopharma Inc. — CURRENT REPORT
Items: 5.02
OfficialSEC EDGARHow this scored
- IPO+0.44 ptsdecay ×0.89Form 8-K current report: base 8 × strength low × source quality 1.00 (tier 1) × corroboration 1.00 (0 independent) × confidence 0.95
- items
- 5.02
- formType
- 8-K
- accessionNumber
- 0001683168-26-006777
Showing the 4 most recent of 46 scored events, from the last 30 days. Every one above is real, with its own source and scoring arithmetic.
ProEvery event, not only the most recent
The full history is 46 events. The 4 most recent are above with their evidence intact — Pro removes the window rather than unlocking anything hidden inside it.
- All 46 events, with no date window
- The individual signal behind each score component
- Day-over-day change attribution
- Export and graph exploration
SEC filings
| Filed | Form | Description | 8-K items | Seen | Source |
|---|---|---|---|---|---|
| 2026-09-11 | 8-K | FORM 8-K | 8.01 | 10 h ago | sec.gov |
| 2026-09-08 | EFFECT | ,, | 10 h ago | sec.gov | |
| 2026-09-08 | 424B3 | FORM 424B3 | not on record | 3 d ago | sec.gov |
| 2026-08-28 | S-1 | not on record | not on record | 4 d ago | sec.gov |
| 2026-08-28 | 8-K | CURRENT REPORT | 5.02 | 4 d ago | sec.gov |
| 2026-08-14 | SCHEDULE 13G/A | not on record | 4 d ago | sec.gov | |
| 2026-08-13 | SCHEDULE 13G/A | not on record | 4 d ago | sec.gov | |
| 2026-08-13 | 10-Q | FORM 10-Q FOR JUN 2026 | not on record | 4 d ago | sec.gov |
| 2026-08-11 | 4 | not on record | 4 d ago | sec.gov | |
| 2026-08-03 | 8-K | FORM 8-K | 8.01 | 4 d ago | sec.gov |
| 2026-07-20 | 424B5 | PROSPECTUS SUPPLEMENT | not on record | 4 d ago | sec.gov |
| 2026-07-20 | 8-K | FORM 8-K | 1.01,9.01 | 4 d ago | sec.gov |
| 2026-07-10 | 8-K | CURRENT REPORT | 1.01,9.01 | 4 d ago | sec.gov |
| 2026-07-08 | SCHEDULE 13G | not on record | 4 d ago | sec.gov | |
| 2026-06-08 | DEF 14C | DEF 14C | not on record | 4 d ago | sec.gov |
| 2026-05-29 | PRE 14C | PRELIMINARY INFORMATION STATEMENT | not on record | 4 d ago | sec.gov |
| 2026-05-29 | 8-K | CURRENT REPORT | 5.07 | 4 d ago | sec.gov |
| 2026-05-22 | SCHEDULE 13G | not on record | 4 d ago | sec.gov | |
| 2026-05-21 | SCHEDULE 13G | not on record | 4 d ago | sec.gov | |
| 2026-05-19 | 424B4 | PROSPECTUS | not on record | 4 d ago | sec.gov |
| 2026-05-19 | 8-K | CURRENT REPORT | 1.01,8.01,9.01 | 4 d ago | sec.gov |
| 2026-05-18 | EFFECT | ,, | 4 d ago | sec.gov | |
| 2026-05-18 | CORRESP | not on record | 4 d ago | sec.gov | |
| 2026-05-18 | CORRESP | not on record | 4 d ago | sec.gov | |
| 2026-05-14 | CORRESP | not on record | 4 d ago | sec.gov | |
| 2026-05-14 | CORRESP | not on record | 4 d ago | sec.gov | |
| 2026-05-13 | 10-Q | FORM 10-Q FOR MAR 2026 | not on record | 4 d ago | sec.gov |
| 2026-05-12 | S-1 | FORM S-1 | not on record | 4 d ago | sec.gov |
| 2026-05-04 | UPLOAD | not on record | 4 d ago | sec.gov | |
| 2026-04-28 | DRS | not on record | 4 d ago | sec.gov | |
| 2026-04-28 | DRSLTR | not on record | 4 d ago | sec.gov | |
| 2026-04-14 | 4 | not on record | 4 d ago | sec.gov | |
| 2026-04-09 | 8-K | CURRENT REPORT | 2.02,9.01 | 4 d ago | sec.gov |
| 2026-04-03 | 10-K | FORM 10-K FOR DEC 2025 | not on record | 4 d ago | sec.gov |
| 2026-03-31 | NT 10-K | EXTENSION | not on record | 4 d ago | sec.gov |
| 2026-03-09 | 8-K | FORM 8-K | 8.01,9.01 | 4 d ago | sec.gov |
| 2026-03-02 | DEF 14C | FORM DEF 14C | not on record | 4 d ago | sec.gov |
| 2026-02-20 | 8-K | CURRENT REPORT | 5.07 | 4 d ago | sec.gov |
| 2026-02-20 | PRE 14C | PRELIMINARY INFORMATION STATEMENT | not on record | 4 d ago | sec.gov |
| 2026-02-05 | 8-K | CURRENT REPORT | 5.02 | 4 d ago | sec.gov |
Institutional relationships
No relationships detected yet. Relationships are extracted from co-mentions in cited events (banks, tokenization providers, custodians, chains).
Signal contributions
These are the real component scores carrying Sunshine Biopharma Inc. right now — the points each contributes, the weight it carries in its dimension, and how many signals sit behind it.
- Filing Evidence17.8 / 20.0 pts5 signals · 5 decayed signal(s), mass 120.4 → 88.8/100 (k=55) × weight 0.2
- Regulatory Evidence8.7 / 16.0 pts37 signals · 37 decayed signal(s), mass 47.1 → 54.4/100 (k=60) × weight 0.16
- Financial Maturity8.0 / 8.0 ptsCompany attribute · company is already public
- Market Conditions4.0 / 4.0 ptsCompany attribute · 201 S-1/F-1 filings on EDGAR in last 90d vs baseline 60
- Recency3.0 / 3.0 ptsCompany attribute · most recent supporting signal 2d old (recency factor 0.99)
6 further components below 0.1 pts not shown.
41.6 points total, out of 100 available at these weights.
- Regulatory Readiness0.0 / 8.0 ptsCompany attribute · no signals in window
- Recency0.0 / 4.0 ptsCompany attribute · no recent signals
- Explicit Statements0.0 / 18.0 ptsCompany attribute · no signals in window
- Executive Statements0.0 / 8.0 ptsCompany attribute · no signals in window
- Custody Infrastructure0.0 / 7.0 ptsCompany attribute · no signals in window
5 further components below 0.1 pts not shown.
0.0 points total, out of 100 available at these weights.
- Custody0.0 / 12.0 ptsCompany attribute · no signals in window
- Settlement0.0 / 12.0 ptsCompany attribute · no signals in window
- Kyc Aml Readiness0.0 / 10.0 ptsCompany attribute · no signals in window
- Tokenization Provider0.0 / 14.0 ptsCompany attribute · no signals in window
- Blockchain Integration0.0 / 12.0 ptsCompany attribute · no signals in window
3 further components below 0.1 pts not shown.
0.0 points total, out of 100 available at these weights.
ProThe individual signal behind every component
Component-level attribution is on every plan and is shown above in full. What Pro adds here is the row-by-row arithmetic: which filing or article produced each component, and every factor applied to it.
- Every contributing signal with its own row
- Base weight, strength, source quality, corroboration, confidence and decay per signal
- The source document behind each line
- Day-over-day change attribution
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.